Medical Ethics has recently announced their pain relief technology, Tri-Solfen, has now entered trials to for us in humans.The technology was borne out of a crisis in the now-booming wool industry when animal welfare activists targeted mulesing, a procedure where farmers remove skin from around the tail area of lambs to reduce the risk of fly strike. Tri-Solfen has already been used to treat about 70 million sheep in Australia under the product licensing deal with Bayer and was approved for use in calves in 2016. International experts in wound care in humans, including Professor Keith Harding at Cardiff University and the Wales Wound Institute, now see potential for it to be adapted for use in humans.
The full article can be found here.